Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
COVID-19 in Health Workers; Stimulating New White Blood Cells: It's TTHealthWatch! This week's topics also include gene expression and COVID infection, and outbreaks in childcare settings Sep 19, 2020 podcast
Surgery Rates Doubled for High-Risk Prostate Cancer Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
Lower COVID-19 Risk With ADT for Prostate Cancer Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Oral ADT Slashes Heart Risk in Advanced Prostate Cancer Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
Studies Make Case for Hormonal Therapy in nmCRPC Prolonged survival with three different androgen signaling inhibitors May 30, 2020
HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
BMI, Weight Change Linked to Prostate Ca Outcomes Gain or loss of body weight both show risk May 07, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
Bell Ringing Not So Joyous for Cancer Patients? Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
'Shock Jock' Don Imus: Not Your Usual Role Model Often despicable on-air, sure, but his approach to prostate cancer worth emulating Jan 03, 2020
Prostate Cancer and the Waiting Game Active surveillance isn't just about avoiding surgery -- it's also buying time Dec 27, 2019
Beta Blockers No Help in Advanced Prostate Cancer Findings question earlier retrospective data that pointed to possible survival benefit Dec 05, 2019
Docetaxel First May Boost Survival in mCRPC Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
MRI-Guided Ultrasound Zaps Low-Risk Prostate Cancer TULSA devices achieves prostate volume reduction Dec 04, 2019
Why the Lower Risk of Prostate Cancer in Men With Diabetes? Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
In Memory of Gerald Chodak, MD Pioneer of active surveillance for men with low-risk prostate cancer died last week Oct 03, 2019
New Standard in Third-Line Metastatic CRPC Cabazitaxel tops more anti-androgen in patients with "short-ish" response to abiraterone or enzalutamide Oct 01, 2019
How Often Does MRI Miss the Mark in Prostate Ca? Retrospective study finds 21% of patients with prostate cancer pathology did not have ROI on MRI Sep 25, 2019
Gandalf the Grey, the Wizard of Omaha, and Prostate Cancer High-profile celebs and low-risk disease Sep 18, 2019
Consider PSA Before Adding ADT to Salvage Radiation Men with levels below 0.6 ng/mL show no benefit, at risk of other-cause mortality Sep 16, 2019
Mystery! The Vanishing Prostate Tumor Do cancers really disappear spontaneously? Or are they just eluding us? Aug 23, 2019
When Medicare Stops Covering a Test Without Warning Why didn't someone tell me, asks Hans Duvefelt, MD Aug 20, 2019
Newer Prostate Cancer Agents Not Free of Heart Risk Patients with three or more cardiac conditions were at highest risk of early death Aug 14, 2019
Gadzooks! And Egads! Another Dilemma in Prostate Cancer Gadolinium scans present yet another thorny decision for patients on active surveillance Jul 28, 2019
No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
Cancer Surgery Refusal Remains a Problem Older, unmarried, African-American patients more likely to say 'no' Jun 04, 2019
Trials Back Earlier Use of Androgen Receptor Inhibitors Improved survival in metastatic hormone-sensitive prostate cancer Jun 03, 2019
Add-On Metformin Disappoints in Metastatic CRPC No meaningful clinical benefit when paired with docetaxel-prednisone in castration-resistant prostate cancer Jun 02, 2019
Ultrasound Therapy for Prostate Ca Yields High PSA Response PSA falls by 95%, prostate shrinks by 90% in men with localized prostate cancer May 07, 2019
I Have Cancer. Please Don't Call Me a 'Survivor' No chemo, no radiation, no symptoms, a few biopsies -- hardly the stuff of heroism Apr 15, 2019
Digital Rectal Exams: Worth the Trouble? Howard Wolinsky looks for the evidence, and doesn't find much Mar 29, 2019
Black History Month: Talking With Jennifer Webb, MD How mentorship helped her overcome barriers Feb 28, 2019
Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVD Increased hospitalizations seen among all abiraterone-treated patients Feb 27, 2019
Doubling Down on Antiandrogens Improves PFS in Metastatic Prostate Ca But lack of OS data for enzalutamide-ADT may hold it back Feb 15, 2019 video
Immunotherapy Lurches Forward in Prostate Cancer Combination trials in mCRPC yield responses in immunologically "cold" tumor Feb 15, 2019
Surveillance of Low-Risk Prostate Cancer Tripled Radical prostatectomy gained some ground for high-risk disease Feb 12, 2019 video
Radiological Agent Shows Promise in Heavily Treated mCRPC PSA decline of 50% or greater in two-thirds of patients Feb 12, 2019 video
